These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 18310190)

  • 1. Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues.
    Bailey DB; Skinner D; Davis AM; Whitmarsh I; Powell C
    Pediatrics; 2008 Mar; 121(3):e693-704. PubMed ID: 18310190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newborn screening for fragile X syndrome.
    Bailey DB
    Ment Retard Dev Disabil Res Rev; 2004; 10(1):3-10. PubMed ID: 14994282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatricians' attitudes toward expanding newborn screening.
    Acharya K; Ackerman PD; Ross LF
    Pediatrics; 2005 Oct; 116(4):e476-84. PubMed ID: 16199673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical, legal and social issues in newborn screening in the United States.
    Therrell BL
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():52-8. PubMed ID: 15906695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal screening for treatable and untreatable disorders: prospective parents' opinions.
    Plass AM; van El CG; Pieters T; Cornel MC
    Pediatrics; 2010 Jan; 125(1):e99-106. PubMed ID: 20026497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for fragile X syndrome.
    Murray J; Cuckle H; Taylor G; Hewison J
    Health Technol Assess; 1997; 1(4):i-iv, 1-71. PubMed ID: 9414543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A large-scale diagnostic program for the fragile X-syndrome among the mentally retarded. II. Implications for parents and family].
    de Vries LB; Duivenvoorden HJ; Tibben A; Niermeijer MF
    Ned Tijdschr Geneeskd; 1998 Jul; 142(29):1672-5. PubMed ID: 9890807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of prenatal carrier screening for fragile X syndrome.
    Vintzileos AM; Ananth CV; Fisher AJ; Smulian JC; Day-Salvatore D; Beazoglou T; Knuppel RA
    J Matern Fetal Med; 1999; 8(4):168-72. PubMed ID: 10406300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetic testing of children for cancer susceptibility: ethical, legal, and social issues.
    Patenaude AF
    Behav Sci Law; 1996; 14(4):393-410. PubMed ID: 9156420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Policy issues for expanding newborn screening programs: the cystic fibrosis newborn screening experience in the United States.
    Wilfond BS; Gollust SE
    J Pediatr; 2005 May; 146(5):668-74. PubMed ID: 15870672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parental attitudes regarding carrier testing in children at risk for fragile X syndrome.
    McConkie-Rosell A; Spiridigliozzi GA; Rounds K; Dawson DV; Sullivan JA; Burgess D; Lachiewicz AM
    Am J Med Genet; 1999 Jan; 82(3):206-11. PubMed ID: 10215541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical problems with neonatal screening.
    Orzalesi M; Danhaive O
    Ann Ist Super Sanita; 2009; 45(3):325-30. PubMed ID: 19861738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newborn screening for fragile X syndrome.
    Tassone F
    JAMA Neurol; 2014 Mar; 71(3):355-9. PubMed ID: 24395328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening for fragile X syndrome. International experiences].
    Vuust J; Larsen LA; Grønskov K; Nørgaard-Pedersen B; Brøndum-Nielsen K
    Ugeskr Laeger; 2006 Oct; 168(43):3704-9. PubMed ID: 17069733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Content of communication by pediatric residents after newborn genetic screening.
    Farrell MH; La Pean A; Ladouceur L
    Pediatrics; 2005 Dec; 116(6):1492-8. PubMed ID: 16322176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissemination of genetic risk information to relatives in the fragile X syndrome: guidelines for genetic counselors.
    McConkie-Rosell A; Robinson H; Wake S; Staley LW; Heller K; Cronister A
    Am J Med Genet; 1995 Dec; 59(4):426-30. PubMed ID: 8585560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic screening: programs, principles, and research--thirty years later. Reviewing the recommendations of the Committee for the Study of Inborn Errors of Metabolism (SIEM).
    Simopoulos AP;
    Public Health Genomics; 2009; 12(2):105-11. PubMed ID: 19039254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragile X syndrome.
    Welch JL; Williams JK
    Neonatal Netw; 1999 Sep; 18(6):15-22. PubMed ID: 10690095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical, social and legal implications of genetic testing in liver disease.
    van Leeuwen DJ; Bernat JL
    Hepatology; 2006 Jun; 43(6):1195-201. PubMed ID: 16729331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics in dental practice: social and ethical issues surrounding genetic testing.
    Gettig E; Hart TC
    J Dent Educ; 2003 May; 67(5):549-62. PubMed ID: 12809190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.